Author Interviews, Brigham & Women's - Harvard, Mental Health Research, NIH / 19.04.2024

MedicalResearch.com Interview with: Sharon Dekel PhD Principal Investigator Director of the Postpartum Traumatic Stress Disorders Research Program Department of Psychiatry, Massachusetts General Hospital Department of Psychiatry, Harvard Medical School Boston, MA, 02114 MedicalResearch.com: What is the background for this study? Response: Maternal psychopathologies affect a significant number of American women and are the leading complications of childbirth and a significant contributor to maternal death. Maternal (physical) morbidity in the US remain the highest among all countries in the West, suggesting that some women will have a traumatic childbirth experience. The most common mental illness associated with trauma is posttraumatic stress disorder (PTSD). PTSD stemming from childbirth is estimated to affect 6% of delivering women (https://pubmed.ncbi.nlm.nih.gov/28443054/). In high-risk groups, for example women who have unscheduled Cesareans the rate is estimated at 20% or higher (https://pubmed.ncbi.nlm.nih.gov/31041603/.). Although we screen for postpartum depression in hospitals in the USA there is no screening for what we define as childbirth-related PTSD (CB-PTSD). The overarching goal of the Dekel Lab is to develop novel and patient-friendly screening tools to identify women with this disorder. As importantly traumatic childbirth disproportionality affects Black and Latina women (https://pubmed.ncbi.nlm.nih.gov/35598158/). (more…)
Author Interviews, Cannabis / 18.04.2024

MedicalResearch.com Interview with: Amy Kennalley, MBS First Year Medical Student Department of Medical Education Geisinger Commonwealth School of Medicine MedicalResearch.com: What is the background for this study Response: The legalization of medical marijuana (MMJ) and the number of qualifying conditions are expanding across the USA, emphasizing the need to understand the implications of MMJ dispensary distribution for equitable access. Pennsylvania (PA) legalized MMJ in 2016, with the first dispensary opening its doors in 2018. The state currently recognizes 24 medical conditions for MMJ use, including six for which there is insufficient or no evidence for their efficacy as a treatment. Prior research suggests that there is a link between proximity to dispensaries and overall MMJ use. However, a gap exists in our understanding of how dispensary locations might be associated with the specific qualifying conditions for which individuals receive their certification. In response to this knowledge gap, our study delved into the medical marijuana dispensary access in PA and explored associations with both MMJ certifications and the community demographics. Utilizing data from the Pennsylvania Department of Health, we investigated how proximity to MMJ dispensaries related to the proportion of individuals certified for MMJ use within a specific area or Zip Code Tabulation Area. Additionally, we analyzed the proportion of certifications for conditions with varying levels of evidence supporting the efficacy of MMJ. This pioneering study represents the first of its kind in PA, shedding light on the association between MMJ dispensary locations and certifications. Likewise, it is the first in the US to investigate the link between dispensary locations and specific qualifying conditions. By examining these dynamics, we aim to contribute vital insights to inform policy and practice, ensuring equitable access to MMJ treatment for individuals with diverse medical needs. (more…)
AACR, Author Interviews, Biomarkers, Breast Cancer, Cancer Research / 11.04.2024

MedicalResearch.com Interview with: RJ Tesi M.D. CEO and Founder of INmune Bio MedicalResearch.com: What is the background for this study? What are the main findings?
  • MUC4 expression by high-risk breast cancer (HER2+ or TNBC) is a biomarker that predicts resistance to therapy and an increased risk a metastasis. MUC4 expression can be determined at time of biopsy and therapeutic decisions should be adjusted to optimize the chance of response to first line therapy.
This biomarker is easily determined using immunohistochemistry in the diagnostic breast biopsy tissue similar to testing for HER2 expression. Testing for MUC4 can be easily added to the current panel of routine stains obtained at the time of the diagnostic biopsy. Knowing MUC4 status in women with high-risk breast cancer will improve results.
  • Soluble TNF causes the up regulation of immune checkpoint proteins of cells of the TME. This includes CD47 and SIRPa on tumor based macrophages and CTLA4, PD1, LAG3 and TIGIT on T cells in the TME. INB03 is a pan immune checkpoint modulator. Treatment with INB03 downregulates all immune checkpoint proteins on the cells. Downmodulation of all immune checkpoint proteins improves response to immunotherapy.
Currently, monoclonal antibodies targeting immune checkpoint proteins are a mainstay of cancer therapy and cancer drug development. These strategies target one immune checkpoint protein at a time. To date, combination therapy targeting two immune checkpoint proteins has been tried (e.g.: anti-PD1 and anti-CTLA4 combination therapy) with mixed results. Combination immune checkpoint strategies may increase therapeutic response but increase toxicity. INB03 downregulates all immune checkpoint proteins. This is equivalent to giving a patient a 6 antibody cocktail – something that cannot be done in man. As expected, decreased immune checkpoint expression improves response to therapy by converting immunotherapy resistant tumors to immunotherapy sensitive tumors.
  • In TNBC, MUC4 expression predicts both resistance to anti-PD1 therapy and increased risk of distant metastasis. Treatment with INB03 decreases expression of proteins associated with tumor metastasis, decreases the number of metastasis and improves response to anti-PD1 therapy. Early use of INB03 may prevent distal disease and improve tumor control.
(more…)
Author Interviews, Autism, Nature, Pediatrics / 11.04.2024

MedicalResearch.com Interview with: Dr. Andrey Vyshedskiy, PhD Founder and CEO of ImagiRation LLC Neuroscientist, Boston University MedicalResearch.com: What is the background for this study? Response: The common intuitive belief is that language comprehension development follows a linear trajectory: children acquire one grammatical rule at a time. Over 20 years ago, Dr. A. Vyshedskiy, predicted that instead of linear development, language should unfold in three steps corresponding to three language comprehension mechanisms of increasing complexity. The study of 31845 autistic individuals, published today in the journal npj Mental Health Research, validates this prediction. The implications of this discovery are reaching far and wide. The traditional definition of language is highly ambiguous. For some philosophers, “language” is equivalent to a “communication system.” Others argue that “language” must be defined more narrowly, in a way that is unique to humans. The results of the new study streamline terminology for describing different language comprehension mechanisms. The ensuing discussion of which language comprehension mechanisms are unique to humans and which are shared with other apes is expected to be most interesting. (more…)
Author Interviews, Cancer Research, Prostate, Prostate Cancer, Urology, Vaccine Studies / 08.04.2024

MedicalResearch.com Interview with: Sujit Nair, PhD Director of GU Immunotherapy Research Department of Urology Icahn School of Medicine at Mount Sinai MedicalResearch.com: What is the background for this study? How is the vaccine obtained? Response: https://classic.clinicaltrials.gov/ct2/show/NCT03262103 Dr. Tewari is the treating physician and clinical lead on the study.  This is a phase I, open-label, clinical trial (NCT03262103) using a dose escalation strategy in 12 patients diagnosed with clinically localized prostate cancer with plans for surgery. The investigational agent used in the trial is Poly-ICLC, an immune modulator developed by ONCOVIR. Poly-ICLC is a double-stranded RNA that mimics viral activity, thereby stimulating the immune response. (more…)
Author Interviews, Health Care Systems, Kidney Disease, NEJM, NIH, UT Southwestern / 04.04.2024

MedicalResearch.com Interview with: Miguel A. Vazquez, MD Professor of Internal Medicine University of Texas Southwestern Medical Center MedicalResearch.com: What is the background for this study? Response: The main reason to conduct our trial was to improve the care of patients with coexistent chronic kidney disease CKD),  type 2 diabetes and hypertension.   Patients with this triad are at high risk for multiple complications, end stage kidney disease and premature death.   There are effective interventions for these conditions.  Unfortunately, detection and awareness of CKD is low and many patients do not receive interventions that could be beneficial In our study in patients with the coexistent triad of chronic kidney disease, type 2 diabetes, and hypertension the use of an electronic algorithm to identify patients from the electronic health record and practice facilitators embedded in four large health systems to assist primary practitioners deliver evidence-based care did not lower hospitalizations when compared to usual care. (more…)
Author Interviews, Heart Disease, Technology / 03.04.2024

MedicalResearch.com Interview with: Dr. Janarthanan Sathananthan M.D. Chief Medical Officer for Interventional Cardiology Therapies Boston Scientific MedicalResearch.com: What is the background for this study? boston-scientificResponse: Despite significant improvements in the drug-eluting stents that are used to treat patients with coronary artery disease, 10% of the percutaneous coronary interventions (PCIs) in the U.S. today address in-stent restenosis (ISR), which is when a previously stented section of a coronary artery becomes obstructed or narrowed by plaque or scar tissue. These patients require additional intervention to avoid potential complications. In the multicenter, randomized AGENT IDE trial, we evaluated whether the AGENT™ Drug-Coated Balloon (DCB), a balloon catheter coated with anti-restenotic paclitaxel, is superior to an uncoated balloon in patients for treating ISR. The AGENT DCB is currently available in countries outside the U.S. Our goal is to bring this technology to market in the U.S. and finally provide physicians with an alternative to traditional ISR treatments, such as placing additional layers of stents or radiation, which may not provide ideal outcomes in some cases. In October 2023, at the Transcatheter Cardiovascular Therapeutics (TCT) 2023 meeting, we presented the primary endpoint data from our AGENT IDE randomized controlled trial evaluating clinical outcomes in patients with ISR undergoing treatment with the AGENT DCB or conventional balloon angioplasty. The positive results in this primary analysis cohort supported the device’s U.S. Food and Drug Administration (FDA) approval, which we announced on March 1, 2024. Just a few months later, data from the full cohort of 600 patients were published in the Journal of the American Medical Association (JAMA) and shared in a late-breaking presentation at Cardiovascular Research Technologies (CRT) 2024 meeting.  (more…)
Author Interviews, Radiology / 02.04.2024

When a person visits a doctor, they might find tests are needed to determine the cause of problems they are experiencing. Countless tests might be used based on the symptoms the person is experiencing. However, some tests remain very common today. The following are the ones that a doctor might recommend. Biopsy One of the best health care diagnostic tests for suspicious lumps is a biopsy. During this procedure, the doctor removes one or more tissue samples from the body to examine them. They use this test to determine whether a patient has cancer, bone marrow issues, or other health issues. Colonoscopy Doctors request a colonoscopy when they suspect a patient has problems with their large intestine or rectum. They insert a flexible tube with a tiny camera in the tip into the rectum to view changes in the intestine or rectum. If they see suspicious areas, a biopsy can be taken for further testing. (more…)
Author Interviews, CDC, Infections, JAMA / 01.04.2024

MedicalResearch.com Interview with: Susan S. Huang, MD, MPH Chancellor's Professor, Infectious Diseases School of Medicine Department of Epidemiology and Infection Prevention University of California Irvine School of Medicine, Irvine MedicalResearch.com: What is the background for this study? Would you describe the decolonization techniques?  
  • This study arose from a growing concern about the increasing number and presence of antibiotic-resistant bacteria causing colonization and infection in hospitals and long-term care. CDC has had a longstanding interest in the value of regional control of these contagious pathogens and they funded this study. The study was actually in two parts:
    • –1) Simulate various infection prevention strategies in a model and see which works best, and then
    • - 2) Do it in real life. The SHIELD project was the real-life example of our simulation finding that decolonization would work the best to prevent harm from antibiotic-resistant bacteria.
  • The regional idea is that it takes all of us working together – hospitals, nursing homes, and long-term acute care hospitals – to prevent the spread and sharing of contagious pathogens. What we can accomplish together is far greater than what any of us can do alone.
  • In this study, decolonization was the use of topical chlorhexidine antiseptic soap and povidone-iodine nasal ointments to reduce potentially harmful bacteria on the body during times when patients and residents may be at risk for infection. We swapped out bathing and showering soap with CHG in participating facilities and ensured that staff knew to clean the body well, including wounds, devices, and rashes where germs can hide and cause infection. For CHG, this involved 4% rinse off product in the shower and 2% no-rinse CHG for bed baths.
(more…)
Author Interviews, Infections / 01.04.2024

MedicalResearch.com Interview with: Maria Y. Tian, MBS Department of Medical Education Geisinger Commonwealth School of Medicine Scranton PA MedicalResearch.com: What is the background for this study? Response: The antibiotic crisis continues to worsen in the United States (U.S.), which has seen an increasing number of deaths associated with antibiotic resistance, becoming one of the most pressing threats to public health. Concurrently, the availability of effective antibiotics are decreasing, which increases the rates and severity of infections, particularly in patients with respiratory tract infections. Unfortunately, a persistent and pernicious contributing factor to the crisis is the unnecessary prescription of antibiotics. In a previous study, 25% of antibiotics prescribed in the outpatient setting to Medicaid beneficiaries were not associated with a provider visit [2]. Furthermore, among 298 million prescriptions filled by 53 million Medicaid patients between 2004 and 2013, 45% of the prescriptions for antibiotics were made without any clear rationale [2]. In our study, we aimed to provide an up-to-date analysis of antibiotic prescribing in the U.S. through examining the temporal profile of outpatient antibiotic use reported by Medical Expenditure Panel System (MEPS) and geographical patterns of antibiotic prescribing rates among US Medicaid program beneficiaries. This will help identify potentially unnecessary prescriptions and inform stewardship efforts. (more…)
Author Interviews, Opiods, Pain Research / 29.03.2024

MedicalResearch.com Interview with: Jay P. Solgama Medical Student Department of Medical Education Geisinger Commonwealth School of Medicine Scranton PA   MedicalResearch.com: What is the background for this study? Response: The opioid crisis in the United States continues to escalate, with opioid-related deaths increasing by over 800% since 2000. Prescription opioids, particularly oxycodone, have been a contributor to this crisis, with substantial variations in their distribution observed across different states [1,2,3]. Against this backdrop, the study conducted by researchers from the Geisinger Commonwealth School of Medicine aimed to characterize the distribution of oxycodone across US states from 2000 to 2021. By analyzing data from the Drug Enforcement Administration’s comprehensive Automation of Reports and Consolidated Orders System (ARCOS) and the Centers for Disease Control and Prevention Wide-ranging ONline Data for Epidemiologic Research (WONDER) databases, the study sought to identify trends and patterns in oxycodone distribution and their potential implications for opioid-related deaths [4,5]. (more…)
Author Interviews, Breast Cancer, Radiology / 28.03.2024

MedicalResearch.com Interview with: Yolanda Bryce, MD Director, Interventional Radiology Residency Program Memorial Sloan Kettering Cancer Center New York   MedicalResearch.com: What is the background for this study? For whom would this treatment be indicated? Response: The standard of care for local breast cancer includes surgery, however many patients are poor surgical candidates or refuse surgery. I use cryoablation to treat this population. (more…)
Author Interviews, Dermatology, Genetic Research, Nature, Rheumatology / 28.03.2024

MedicalResearch.com Interview with: Chelisa Cardinez PhD Postdoctoral Researcher The Burr Laboratory- Cancer Immunology and Epigenetics Genome Sciences and Cancer Division The John Curtin School of Medical Research The Australian National University Canberra, Australia   MedicalResearch.com: What is the background for this study? Response: Psoriasis is a skin inflammatory disease that affects approximately 2-3% of the population. Previous research had identified that the cytokine IL-17 drives the development of this disease. However, key questions that remained unknown about psoriasis included where did the IL-17 come from, and why do some patients with psoriasis also go on to develop systemic inflammatory conditions such as arthritis. Our research aimed to address these questions using a gain of function (GoF) mouse model that carried a genetic variant in a gene called IKBKB. (more…)
Author Interviews, Dermatology, Kidney Stones, NEJM / 28.03.2024

MedicalResearch.com Interview with: Thomas Robert, MD, AIX Associate Professor of Nephrology APHM (Assistance Publique - Hopitaux de Marseille) Marseille, Provence-Alpes-Côte d'Azur, France   Prof. Emmanuel Letavernier, MD PhD Nephrologist at Tenon Hospital Paris, France MedicalResearch.com: What is the background for this study? Response: Our work was prompted by emerging concerns surrounding the potential nephrotoxic effects of hair-straightening products containing glyoxylic acid. This inquiry was instigated by a patient who experienced three repeated acute episodes of kidney injury in June 2020, April 2021, and July 2022, each occurring shortly after a hair-straightening procedure. Notably, these episodes resolved with hydration. Upon examining the composition of the hair product used by the patient, which contained glyoxylic acid, and considering the patient's report of  painful ulcer scalp during application and subsequent scalp scarring, we suspected a potential link between exposure to glyoxylic acid and kidney injury. Consulting with my colleague, Professor Emmanuel Letavenier, a specialist in crystalline nephropathy at Paris, confirmed this suspicion. In summer 2023, cases series have been reported by an Israeli team (https://pubmed.ncbi.nlm.nih.gov/36610611/), who described 26 patients presenting with acute renal injuries after hair straightening treatments. Biopsies revealed calcium oxalate crystals in the kidneys. The Israeli researchers suspected an effect of formaldehyde and glycolic acid, another substance found in many cosmetic products, including hair straightening products, but were unable to provide conclusive evidence. (more…)
Author Interviews, OBGYNE / 26.03.2024

Pelvic health is an underappreciated component of overall health. Many people suspect that only doctors can help with pelvic issues such as incontinence, painful intercourse or constipation. Physical therapy Gilbert AZ for the pelvis can address many of these issues and provide relief in tandem with medical therapies. Pelvic floor physical therapy is very common and can drastically improve patients' quality of life. (more…)
Author Interviews, JAMA, Pediatrics, USPSTF / 26.03.2024

MedicalResearch.com Interview with: James Stevermer, M.D., M.S.P.H. Vice chair for clinical affairs Professor of family and community medicine University of Missouri Medical director of MU Health Care Family Medicine–Callaway Physicians, Dr. Stevermer joined the U.S. Preventive Service Task Force in January 2021. MedicalResearch.com: What is the background for this study? Response: Child abuse and neglect is a serious problem that affects too many kids and teens across the United States. This type of maltreatment can have a profound effect on their health, development, and well-being, both when they are young and into adulthood. (more…)
Alzheimer's - Dementia, Author Interviews, JAMA, UC Davis / 25.03.2024

MedicalResearch.com Interview with: Charles DeCarli, MD, FAAN, FAHA Victor and Genevieve Orsi Chair in Alzheimer's Research Distinguished Professor of Neurology Director, Alzheimer's Disease Research Center and Imaging of Dementia and Aging (IDeA) Laboratory Department of Neurology and Center for Neuroscience University of California at Davis Sacramento, CA  95817   MedicalResearch.com: What is the background for this study? Response: The overall health of the U.S. population has improved dramatically over the last 100 years, Individuals are also living longer resulting in an increasing percentage of the population at risk for Alzheimer’s disease and related dementias (ADRD).  Recent data from the Framingham Heart study, however, finds that dementia incidence may be declining.  While many factors such as greater educational achievement and medical management of vascular risk factors may explain part of this effect, early life environmental differences also likely contribute. (more…)
Accidents & Violence, Author Interviews, Environmental Risks / 25.03.2024

MedicalResearch.com Interview with: Donald A. Redelmeier, MD, MS(HSR); Canada Research Chair Medical Decision Sciences Professor of Medicine University of Toronto MedicalResearch.com: What is the background for this study? Response: The arrival of a solar eclipse attracts substantial public attention and superstitions about supernatural forces. We wondered whether the risk of solar retinopathy might not be the only health hazard since the celestial event leads to increases in driving and potentially increases in traffic deaths. (more…)
Author Interviews, Cancer Research, Prostate Cancer, Radiology / 25.03.2024

MedicalResearch.com Interview with: Steven S. Raman, M.D., FASR, FSIR Professor of Radiology, Urology and Surgery David Geffen School of Medicine UCLA MedicalResearch.com: What is the background for this study? Would you describe the TULSA technique? Response: Prostate cancer is the most common solid organ cancer in men.  Currently whole gland ablation relies on surgery or radiation both of which have high rates of impotence and incontinence but also have up to a 30% rate of post therapy recurrence. TULSA is a new minimally invasive technique to treat PCa under MRI guidance with both near continuous whole gland MRI imaging and MRI thermometry to make sure the extent of lethal heating over 55 degrees Celsius is known.  (more…)
Addiction, Author Interviews, Cancer Research, Cannabis / 23.03.2024

MedicalResearch.com Interview with: Brian J. Piper, PhD Associate Professor of Neuroscience Geisinger Commonwealth School of Medicine Scranton PA 18411 MedicalResearch.com: What is the background for this study? Response: Many cancer patients use marijuana to treat pain, nausea, or anxiety, often without communicating this with their health care providers. Two observational studies (1, 2) from a single institution in Israel purporting to find a dangerous drug interaction between medical cannabis and immunotherapy have been cited hundreds of times, including by clinical practice guidelines. The cannabinoid CB2 receptor is found on immune tissues so it is biologically possible that marijuana could make immunotherapies like nivolumab less effective. However, there were anonymous reports on PubPeer (3-5) of many irregularities in the data-analysis. If there were unappreciated differences on other important variables at baseline besides subsequent cannabis use, this could change the interpretation of these influential reports (1, 2). This investigation involved attempting to repeat and verify the data-analysis. (more…)
Author Interviews, OBGYNE / 19.03.2024

MedicalResearch.com Interview with: Chelsea A DeBolt, MD Assistant Professor, Obstetrics, Gynecology and Reproductive Science Division of Maternal-Fetal Medicine Icahn School of Medicine at Mount Sinai MedicalResearch.com: What is the background for this study? Response: Significant immunological shifts, systemically and at the maternal-fetal interface, are required for a successful pregnancy. Yet, there is a paucity of comprehensive data investigating the systemic immune changes within the same individual transitioning from the non-pregnant to pregnant state. (more…)
Author Interviews, Brigham & Women's - Harvard, Infections, JAMA, Multiple Sclerosis, Neurological Disorders / 19.03.2024

MedicalResearch.com Interview with: Marianna Cortese, MD, PhD Senior Research ScientistDepartment of Nutrition Harvard T.H. Chan School of Public HealthBoston, MA 02115   MedicalResearch.com: What is the background for this study? Response: In a study published in Science in 2022, we reported compelling evidence that infection with the Epstein-Barr virus is the leading cause of Multiple Sclerosis. This is a follow-up study to investigate more in depth whether the antibody response to EBV is distinct in individuals with MS compared to individuals without MS and whether there is a part of EBV that the immune response is particularly targeting. For this purpose we assessed the immune response to all protein parts (peptides) of EBV and their association with MS. Previous studies could only look at parts of EBV and this is the first study looking at all EBV peptides. Antibodies to EBV (especially to a protein called EBNA1) are known to be overall higher in individuals with MS, so we also tested whether immune response overall or the immune response to specific EBV protein parts was more important. If the immune response to a specific EBV protein part (peptide) would be standing out or distinguishing individuals with MS, we hypothesized, it could point to a specific mechanism of how EBV may cause MS, i.e. it could point for example towards “molecular mimicry”, which is when antibodies targeting a pathogen start targeting a body-own structure (for example in the brain) which resembles the protein parts of the pathogen. (more…)
Author Interviews, Colon Cancer, JAMA / 19.03.2024

MedicalResearch.com Interview with: Eric Montminy MD Interventional Endoscopist Cook County Health and Hospitals System Chicago, Illinois   MedicalResearch.com: What is the background for this study? Response: This study was performed in the backdrop of recent colorectal cancer screening guideline updates.  Two national organizations are recommending screening initiation at two different ages: USPSTF recommends initiation at age 45 and the American College of Physicians (ACP) recommends initiation at age 50. With now two national organizations recommending different ages to start screening, patients may become confused (particularly those between 45-50).  Prior confusion has been documented when breast cancer screening recommendations were being changed as well.  Our focus was to examine colorectal adenocarcinoma incidence rates with stage stratification of those who are between the ACP and USPSTF recommendations (ages 46-49). Our study utilized SEER17 data registries over 2000-2020 to collect incidence rates within the U.S.  (more…)
Author Interviews, Environmental Risks, Infections, PNAS / 14.03.2024

MedicalResearch.com Interview with: Dr. Fangqun Yu PhD Senior Research Faculty Atmospheric Sciences Research Center University Albany, State University of New York https://www.albany.edu/~yfq   Dr. Arshad Arjunan Nair PhD Postdoctoral Associate Atmospheric Sciences Research Center University at Albany, State University of New York https://www.albany.edu/~an688965   MedicalResearch.com: What is the background for this study? What are the main findings? Dr. Fangqun Yu: Legionnaires’ disease is a severe form of pneumonia with a fatality rate of 10-25% caused by inhaling or aspirating Legionella, bacteria that thrive in built environment water systems. Those most vulnerable to this disease are male, over 50 years of age, have a history of smoking, have chronic respiratory diseases, diabetes, are immunocompromised, and/or minorities. The US observed a nearly nine-fold increase in Legionnaires’ disease between 2000 and 2018, with New York State having one of the highest increases in disease rates. The reasons for the increase in incidence were unclear prior to this study. In our study, we found: (1) Declining sulfur dioxide concentrations (SO2) are strongly correlated with the increase in legionellosis cases and a physical mechanism explaining this link is proposed, (2) A geostatistical epidemiological analysis links the disease with exposure to cooling towers, and (3) Climate and weather are ruled out as factors responsible for the long-term increase in case numbers (outside of seasonal trends). (more…)
Author Interviews, COVID -19 Coronavirus, Infections, NYU / 14.03.2024

MedicalResearch.com Interview with: Mukundan G. Attur, PhD Associate Professor, Department of Medicine NYU Grossman School of Medicine MedicalResearch.com: What is the background for this study? What are the main findings? Response:  The study investigates the potential protective effects of a genetic variant of IL1RN against inflammation and severe outcomes, particularly in COVID-19. Previous research indicates that carriers of this genetic variant may experience less severe radiographic knee osteoarthritis and decreased inflammation in rheumatoid arthritis patients. Given the emergence of cytokine release syndrome in COVID-19 patients, the researchers sought to understand whether the same genetic variant could offer protection against inflammation and potential death in COVID-19 cases. (more…)
Author Interviews, Sleep Disorders / 12.03.2024

MedicalResearch.com Interview with: Soomi Lee, PhD Associate Professor | Department of Human Development and Family Studies | Center for Healthy Aging Director of STEALTH Lab: https://sites.psu.edu/stealth/ The Pennsylvania State University MedicalResearch.com: What is the background for this study? Response:  Sleep quantity and quality decline with advancing age; a risk of chronic conditions also increases with age. While previous studies report that poor sleep is a significant risk for chronic conditions, many have focused solely on a single dimension of sleep, such as duration, thereby limiting the ability to assess multiple co-occurring dimensions and their associations with chronic conditions. This study aimed to evaluate multiple dimensions of sleep health, including regularity, satisfaction, alertness, efficiency, and duration. By analyzing data from a national sample of adults (n=3,683) collected over two time points spanning a decade, the study identified four distinct sleep health phenotypes: good sleepers, insomnia sleepers, weekend catch-up sleepers, and nappers. (more…)
Author Interviews / 09.03.2024

Precision in healthcare isn't just important; it's an absolute non-negotiable. Consider how anxiety-inducing a world where health information wasn't treated with absolute care, accuracy, and precision would be. Transcription, the process of converting spoken words into written text, is indispensable to the medical world. Medical scribes transcribe by recording important details of physician-patient encounters, while clinical researchers must convert their findings into analysable written text to ensure their validity and create opportunities for further learning and understanding of their results. So, let's explore six main ways transcription supports the precision and integrity of healthcare.

Enhancing Accuracy and Precision

medical-scribes-dictationSkilled medical scribing entails meticulous transcription of patient encounters, procedures, or treatment plans from spoken word into written text, capturing every detail and nuance. Transcription is a pivotal tool for ensuring that the physician follows the proper procedure and that medical records, reports, and documentation have perfect levels of accuracy. Medical scribing is a skilled profession that requires solid knowledge of the worker's chosen healthcare field. Any misinterpretation of patient information has the potential to lead to ill-informed future decisions regarding a patient's health. Healthcare organisations must also adhere to strict guidelines regarding the documentation of patient care, billing processes, and confidentiality protocols. Skilled medical scribes with specialised knowledge and expertise in their industry can protect organisations from costly lawsuits and ensure that patients are treated with the correct level of integrity. In today's world, time is money. Successful medical scribes improve efficiency and take the burden off physicians having to personally record data, enabling them to see more patients and listen more attentively, ultimately contributing to reaching the healthcare company's overall productivity and financial aims. One study found that medical scribes cut costs by $31.15 per hour, with no risk added risk to patient safety. (more…)
ADHD, Author Interviews, Dermatology, JAMA, Mental Health Research / 08.03.2024

MedicalResearch.com Interview with: Dr. Joy Wan M.D., M.S.C.E. Assistant Professor of Dermatology Johns Hopkins University School of Medicine MedicalResearch.com: What is the background for this study? Response: There has been a growing body of literature linking atopic dermatitis with diagnoses such as ADHD and learning disabilities, but studies focusing on symptoms of cognitive impairment (in contrast to relying on reported diagnoses as proxy measures of such) have been fewer and demonstrate inconsistent findings. Thus, we were interested in using data from this nationally representative sample of U.S. children to examine whether atopic dermatitis was associated with symptoms of learning or memory difficulties. Moreover, we wanted to examine how this relationship is influenced by known neurodevelopmental conditions to further characterize whether specific subgroups of children with atopic dermatitis are more susceptible to cognitive impairments. (more…)
Author Interviews, Cancer Research, Microbiome / 07.03.2024

MedicalResearch.com Interview with: Dr Ashray Gunjur MBBS (Hons), B. Med Sci, MPHTM FRACP Clinical Research Training Fellow Melbourne, Australia   MedicalResearch.com: What is the background for this study? Response: As background, the last ~5 years have seen a surge of interest in the relationship between gut microbiota and cancer response to immune checkpoint blockade (ICB). We know that though a fraction of many different cancer types will respond to these therapies, it is currently very hard to predict who that will be- so ‘microbiome’ based biomarkers to select patients, or even strategies to change a patient’s microbiome to enhance their chance of responding, are very attractive. A key challenge, however, has been a lack of consistency in the microbes associated with response or non-response across different studies from different regions. While geographic, methodological, and technical variation likely contribute to this, most studies examined the gut microbiome at a genus- or species- taxonomic rank level, while we know there is significant intra-species (strain-level) diversity. As such, one of our key research questions was whether we could improve the reproducibility of microbial ‘signatures’ of response across cohorts using higher resolution approaches- with our hypothesis being that strain-resolution signatures would outperform species- or lower resolution signatures. We obtained our signature by analysing baseline faecal samples from the CA209-538 clinical trial, a wonderful investigator-initiated study sponsored by the Olivia Newton-John Cancer Research Institute (Melbourne, Australia). I was fortunate enough to work on this trial as a clinical investigator while training to be a medical oncologist. (more…)
Author Interviews, Cognitive Issues, COVID -19 Coronavirus, Imperial College, NEJM / 29.02.2024

MedicalResearch.com Interview with: Prof. Adam Hampshire Ph.D. Faculty of Medicine, Department of Brain Sciences Professor in Restorative Neurosciences Imperial College London MedicalResearch.com: What is the background for this study? Response: Cognitive symptoms after coronavirus disease 2019 (Covid-19), the disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), are well-recognized. Whether objectively measurable cognitive deficits exist and how long they persist are unclear. (more…)